Free Trial
OTCMKTS:LABFF

Laboratorios Farmaceuticos Rovi (LABFF) Stock Price, News & Analysis

Laboratorios Farmaceuticos Rovi logo
C$65.86 0.00 (0.00%)
As of 04/29/2025

About Laboratorios Farmaceuticos Rovi Stock (OTCMKTS:LABFF)

Key Stats

Today's Range
C$65.86
C$65.86
50-Day Range
C$65.86
C$65.86
52-Week Range
C$65.86
C$65.86
Volume
N/A
Average Volume
1,300 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas. Its principal products include Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa; and hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express, Fibrilin, and Sodium Heparin Rovi. It also provides contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, and sachets. Laboratorios Farmaceuticos Rovi, S.A. was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.

Receive LABFF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Laboratorios Farmaceuticos Rovi and its competitors with MarketBeat's FREE daily newsletter.

LABFF Stock News Headlines

Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.
Laboratorios Farmaceuticos Rovi (0ILL) Gets a Buy from Kepler Capital
ROVI Corrects English Communication Error
See More Headlines

LABFF Stock Analysis - Frequently Asked Questions

Laboratorios Farmaceuticos Rovi's stock was trading at C$65.86 at the beginning of 2025. Since then, LABFF shares have increased by 0.0% and is now trading at C$65.86.
View the best growth stocks for 2025 here
.

Shares of LABFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:LABFF
CIK
N/A
Fax
N/A
Employees
1,925
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (OTCMKTS:LABFF) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners